Cargando…

PPAR Gamma agonists regulate tobacco smoke-induced toll like receptor 4 expression in alveolar macrophages

BACKGROUND: Peroxisome proliferator-activated receptor-gamma (PPARγ) is a ligand-activated transcription factor that exerts multiple biological effects. Growing evidence suggests that PPARγ plays an important role in inflammation; however, the effects of this transcription factor on the inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Yan, Hou, Gang, Li, Erran, Wang, Qiuyue, Kang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007599/ https://www.ncbi.nlm.nih.gov/pubmed/24612634 http://dx.doi.org/10.1186/1465-9921-15-28

Ejemplares similares

PPARs in Alveolar Macrophage Biology
por: Smith, Monica R., et al.
Publicado: (2007)

Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-γ Agonists
por: Gurley, Catherine, et al.
Publicado: (2008)

Peroxisome Proliferator-Activated Receptor (PPARγ) Plays a Protective Role in Cigarette Smoking-Induced Inflammation via AMP-Activated Protein Kinase (AMPK) Signaling
por: Wang, Lingling, et al.
Publicado: (2018)

Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes
por: Juarez, Esmeralda, et al.
Publicado: (2010)

Impaired Innate COPD Alveolar Macrophage Responses and Toll-Like Receptor-9 Polymorphisms
por: Berenson, Charles S., et al.
Publicado: (2015)

The effects of repeated Toll-like receptors 2 and 4 stimulation in COPD alveolar macrophages
por: Lea, Simon R, et al.
Publicado: (2018)

Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients
por: Droemann, Daniel, et al.
Publicado: (2005)

Effects of budesonide on toll-like receptor expression in alveolar macrophages from smokers with and without COPD
por: Ji, Jie, et al.
Publicado: (2016)

Toll-like Receptor agonists and alpha-galactosylceramide synergistically enhance the production of interferon-gamma in murine splenocytes
por: Ando, Tatsuya, et al.
Publicado: (2013)

PPAR-Gamma Agonist Pioglitazone Reduced CD68+ but Not CD163+ Macrophage Dermal Infiltration in Obese Psoriatic Patients
por: Yemchenko, Ya. O., et al.
Publicado: (2020)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages
por: Feng, Yanxian, et al.
Publicado: (2019)

Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?
por: Carta, Anna R., et al.
Publicado: (2011)

Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver
por: Rogue, Alexandra, et al.
Publicado: (2010)

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

Alveolar Macrophage Heterogeneity Goes up in Smoke?
por: Tabary, Mohammadreza, et al.
Publicado: (2022)

Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011)

Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide
por: Shen, Kuan-Yin, et al.
Publicado: (2014)

PPAR-alpha/gamma agonists, glucagon-like peptide-1 receptor agonists and metformin for non-alcoholic fatty liver disease: A network meta-analysis
por: Zhang, Zhuo-Ya, et al.
Publicado: (2023)

Apoptosis rate and transcriptional response of pancreatic islets exposed to the PPAR gamma agonist Pioglitazone
por: Lamounier, Rodrigo N, et al.
Publicado: (2013)

Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages
por: Karimi, Khalil, et al.
Publicado: (2006)

The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
por: Stunes, Astrid K, et al.
Publicado: (2011)

Differential cell reaction upon Toll-like receptor 4 and 9 activation in human alveolar and lung interstitial macrophages
por: Hoppstädter, Jessica, et al.
Publicado: (2010)

Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
por: Rolfo, Christian, et al.
Publicado: (2023)

The Toll-Like Receptor Agonist Imiquimod Is Active against Prions
por: Oumata, Nassima, et al.
Publicado: (2013)

Trial Watch: Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Toll-like receptor agonists in oncological indications
por: Aranda, Fernando, et al.
Publicado: (2014)

Anti-tumor Activity of Toll-Like Receptor 7 Agonists
por: Chi, Huju, et al.
Publicado: (2017)

The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
por: Huang, Lingling, et al.
Publicado: (2022)

Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
por: Wang, Limei, et al.
Publicado: (2014)

Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma
por: Deng, Shuanglin, et al.
Publicado: (2014)

Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis
por: Park, Arum, et al.
Publicado: (2019)

The phosphoproteome of toll-like receptor-activated macrophages
por: Weintz, Gabriele, et al.
Publicado: (2010)

Testing the PPAR hypothesis of tobacco use disorder in humans: A randomized trial of the impact of gemfibrozil (a partial PPARα agonist) in smokers
por: Gendy, Marie N. S., et al.
Publicado: (2018)

Ursolic acid alleviates airway-vessel remodeling and muscle consumption in cigarette smoke-induced emphysema rats
por: Lin, Li, et al.
Publicado: (2019)

Synthesis and Immunological Characterization of Toll-Like Receptor 7 Agonistic Conjugates
por: Chan, Michael, et al.
Publicado: (2009)

Toll-like receptor 2 agonists inhibit human fibrocyte differentiation
por: Maharjan, Anu S, et al.
Publicado: (2010)

Trial Watch: Experimental Toll-like receptor agonists for cancer therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies
por: Martinsen, Janne Tegder, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_umnq0osa1d345t8c3tql64a34p